General Information of the Compound
| Compound ID |
CP0873040
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(4-(1-cyclobutylpiperidin-4-yloxy)phenyl)-4-(4-methylbenzoyl)piperazin-2-one hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H34ClN3O3
|
||||||||||||||||||
| Molecular Weight |
484.04
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H33N3O3.ClH/c1-20-5-7-21(8-6-20)27(32)29-17-18-30(26(31)19-29)23-9-11-24(12-10-23)33-25-13-15-28(16-14-25)22-3-2-4-22;/h5-12,22,25H,2-4,13-19H2,1H3;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
GFGGZTNVJUNZEE-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2